Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1CNS 1

Conditions

Pituitary Diseases 1Obesity 1Neoplasms 1Hypoglycemia 1Hyperinsulinism 1Gastro-enteropancreatic neuroendocrine tumor 1Craniopharyngioma 1

Interventions

Surgical Procedures, Operative 3Exenatide 3tocilizumab 2Surveys and Questionnaires 2Radiotherapy 2Proton Therapy 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Donepezil 2trametinib 1tozuleristide 1tovorafenib 1temsirolimus 1gallium Ga 68 dotatate 1dabrafenib 1cobimetinib 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1anlotinib 1Vemurafenib 1Tumor Burden 1Transurethral Resection of Bladder 1Thalidomide 1Temozolomide 1Radiotherapy, Image-Guided 1Radiation 1Qsymia 1Prednisone 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Craniopharyngioma × Diazoxide × Clear all
NCT00306683 2011-02-18

Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
40 enrolled
CNSEndocrineOther

Craniopharyngioma, Hyperinsulinism, Neoplasms, Obesity, Pituitary Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡